Literature DB >> 26752689

Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women.

Virginia M Miller1, Brian D Lahr2, Kent R Bailey3, Howard N Hodis4, Sharon L Mulvagh5, Muthuvel Jayachandran6.   

Abstract

BACKGROUND: Decreases in endothelial function measured by reactive hyperemic index (RHI) correlated with increases in carotid intima-media thickness (CIMT) in recently menopausal women with a low risk cardiovascular profile. Factors linking this association are unknown.
OBJECTIVE: Assess, longitudinally, markers of platelet activation and cell-derived, blood-borne microvesicles (MV) in relationship to RHI and CIMT in asymptomatic, low risk menopausal women.
METHODS: RHI by digital pulse tonometry (n = 93), CIMT by ultrasound (n = 113), measures of platelet activation and specific cell-derived, blood-borne MV were evaluated in women throughout the Kronos Early Estrogen Prevention Study (KEEPS) at Mayo Clinic.
RESULTS: CIMT, but not RHI, increased significantly over 4 years. The average change in CIMT correlated significantly with the average follow-up values of MV positive for common leukocyte antigen [CD45; ρ = 0.285 (P = 0.002)] and VCAM-1 [ρ = 0.270 (P = 0.0040)]. Using principal components analysis (PC) on the aggregate set of average follow-up measures, the first derived PC representing numbers of MV positive for markers of vascular endothelium, inflammatory cells (leukocyte and monocytes), pro-coagulant (tissue factor), and cell adhesion molecules (ICAM-1 and VCAM-1) associated with changes in RHI and CIMT. Changes in RHI associated with another PC defined by measures of platelet activation (dense granular ATP secretion, surface expression of P-selectin and fibrinogen receptors).
CONCLUSIONS: MV derived from activated endothelial and inflammatory cells, and those expressing cell adhesion and pro-coagulant molecules may reflect early vascular dysfunction in low risk menopausal women. Assays of MV as non-conventional measures to assess cardiovascular risk in asymptomatic women remain to be developed.
Copyright © 2015 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Inflammation; KEEPS; Kronos Early Estrogen Prevention Study; Leukocytes; Microparticles; Platelets

Mesh:

Substances:

Year:  2015        PMID: 26752689      PMCID: PMC4764461          DOI: 10.1016/j.atherosclerosis.2015.12.030

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  38 in total

1.  Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.

Authors:  Nicolas Amabile; Alain P Guérin; Aurélie Leroyer; Ziad Mallat; Clément Nguyen; Jacques Boddaert; Gérard M London; Alain Tedgui; Chantal M Boulanger
Journal:  J Am Soc Nephrol       Date:  2005-09-28       Impact factor: 10.121

Review 2.  Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).

Authors:  Michel Félétou; Paul M Vanhoutte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-21       Impact factor: 4.733

3.  Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.

Authors:  S Mitchell Harman; Dennis M Black; Frederick Naftolin; Eliot A Brinton; Matthew J Budoff; Marcelle I Cedars; Paul N Hopkins; Rogerio A Lobo; JoAnn E Manson; George R Merriam; Virginia M Miller; Genevieve Neal-Perry; Nanette Santoro; Hugh S Taylor; Eric Vittinghoff; Mingzhu Yan; Howard N Hodis
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

4.  High precision platelet releasate definition by quantitative reversed protein profiling--brief report.

Authors:  Patrick Wijten; Thijs van Holten; Liy Liy Woo; Onno B Bleijerveld; Mark Roest; Albert J R Heck; Arjen Scholten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-02       Impact factor: 8.311

5.  Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Authors:  H N Hodis; W J Mack; R A Lobo; D Shoupe; A Sevanian; P R Mahrer; R H Selzer; C R Liu Cr; C H Liu Ch; S P Azen
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

6.  Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease.

Authors:  Nikos Werner; Sven Wassmann; Patrick Ahlers; Sonja Kosiol; Georg Nickenig
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-20       Impact factor: 8.311

Review 7.  Endothelial microparticles as markers of endothelial dysfunction.

Authors:  Lawrence L Horstman; Wenche Jy; Joaquin J Jimenez; Yeon S Ahn
Journal:  Front Biosci       Date:  2004-05-01

8.  Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction.

Authors:  Daniel Bulut; Karin Maier; Nadine Bulut-Streich; Jan Börgel; Christoph Hanefeld; Andreas Mügge
Journal:  J Card Fail       Date:  2008-05       Impact factor: 5.712

9.  Endothelial function and cardiovascular risk stratification in menopausal women.

Authors:  S L Mulvagh; T Behrenbeck; B A Lahr; K R Bailey; T G Zais; P A Araoz; V M Miller
Journal:  Climacteric       Date:  2010-02       Impact factor: 3.005

10.  Endothelial and platelet microparticles in vasculitis of the young.

Authors:  P A Brogan; V Shah; C Brachet; A Harnden; D Mant; N Klein; M J Dillon
Journal:  Arthritis Rheum       Date:  2004-03
View more
  14 in total

Review 1.  Extracellular vesicles in cardiovascular diseases.

Authors:  Shihui Fu; Yujie Zhang; Yulong Li; Leiming Luo; Yali Zhao; Yao Yao
Journal:  Cell Death Discov       Date:  2020-07-30

2.  Moderate-intensity exercise reduces activated and apoptotic endothelial microparticles in healthy midlife women.

Authors:  Corinna Serviente; Amy Burnside; Sarah Witkowski
Journal:  J Appl Physiol (1985)       Date:  2018-09-20

3.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022

4.  Cerebrovascular Reactivity and Vascular Activation in Postmenopausal Women With Histories of Preeclampsia.

Authors:  Jill N Barnes; Ronée E Harvey; Kathleen B Miller; Muthuvel Jayachandran; Katherine R Malterer; Brian D Lahr; Kent R Bailey; Michael J Joyner; Virginia M Miller
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

Review 5.  Extracellular Vesicles as Messengers in Atherosclerosis.

Authors:  Mengna Peng; Xinfeng Liu; Gelin Xu
Journal:  J Cardiovasc Transl Res       Date:  2019-10-29       Impact factor: 4.132

6.  Low MT-CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease.

Authors:  Paul Holvoet; Maarten Vanhaverbeke; Katarzyna Bloch; Pieter Baatsen; Peter Sinnaeve; Stefan Janssens
Journal:  J Am Heart Assoc       Date:  2016-12-05       Impact factor: 5.501

7.  Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study.

Authors:  Jan K Nowak; Irena Wojsyk-Banaszak; Edyta Mądry; Andrzej Wykrętowicz; Patrycja Krzyżanowska; Sławomira Drzymała-Czyż; Agata Nowicka; Andrzej Pogorzelski; Ewa Sapiejka; Wojciech Skorupa; Mariusz Szczepanik; Aleksandra Lisowska; Jaroslaw Walkowiak
Journal:  Lung       Date:  2017-06-23       Impact factor: 2.584

Review 8.  Extracellular vesicles in cardiovascular diseases.

Authors:  Shihui Fu; Yujie Zhang; Yulong Li; Leiming Luo; Yali Zhao; Yao Yao
Journal:  Cell Death Discov       Date:  2020-07-30

9.  Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.

Authors:  V M Miller; H S Taylor; F Naftolin; J E Manson; C E Gleason; E A Brinton; J M Kling; M I Cedars; N M Dowling; K Kantarci; S M Harman
Journal:  Climacteric       Date:  2020-09-03       Impact factor: 3.005

Review 10.  The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease.

Authors:  Lee Ohayon; Xinyi Zhang; Partha Dutta
Journal:  Pharmacol Res       Date:  2021-06-25       Impact factor: 10.334

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.